357 related articles for article (PubMed ID: 28826308)
1. The influence of breathing motion and a variable relative biological effectiveness in proton therapy of left-sided breast cancer.
Ödén J; Toma-Dasu I; Eriksson K; Flejmer AM; Dasu A
Acta Oncol; 2017 Nov; 56(11):1428-1436. PubMed ID: 28826308
[TBL] [Abstract][Full Text] [Related]
2. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
3. Effect of breathing motion on robustness of proton therapy plans for left-sided breast cancer patients with indication for locoregional irradiation.
Klaassen L; Petoukhova AL; Habraken SJM; Jacobs J; Sattler MGA; Verhoeven K; Klaver YLB
Acta Oncol; 2021 Feb; 60(2):222-228. PubMed ID: 33269958
[TBL] [Abstract][Full Text] [Related]
4. The dirty and clean dose concept: Towards creating proton therapy treatment plans with a photon-like dose response.
Heuchel L; Hahn C; Ödén J; Traneus E; Wulff J; Timmermann B; Bäumer C; Lühr A
Med Phys; 2024 Jan; 51(1):622-636. PubMed ID: 37877574
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of relative biological effectiveness uncertainties into proton plan robustness evaluation.
Ödén J; Eriksson K; Toma-Dasu I
Acta Oncol; 2017 Jun; 56(6):769-778. PubMed ID: 28464736
[TBL] [Abstract][Full Text] [Related]
6. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
[TBL] [Abstract][Full Text] [Related]
7. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk after breast proton therapy considering physiological and radiobiological uncertainties.
Raptis A; Ödén J; Ardenfors O; Flejmer AM; Toma-Dasu I; Dasu A
Phys Med; 2020 Aug; 76():1-6. PubMed ID: 32563956
[TBL] [Abstract][Full Text] [Related]
9. Respiratory gating for proton beam scanning versus photon 3D-CRT for breast cancer radiotherapy.
Flejmer AM; Edvardsson A; Dohlmar F; Josefsson D; Nilsson M; Witt Nyström P; Dasu A
Acta Oncol; 2016 May; 55(5):577-83. PubMed ID: 27027913
[TBL] [Abstract][Full Text] [Related]
10. Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β.
Paganetti H
Acta Oncol; 2017 Nov; 56(11):1379-1386. PubMed ID: 28918679
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of dose-averaged linear energy transfer (LET
Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB
Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809
[TBL] [Abstract][Full Text] [Related]
12. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
Traneus E; Ödén J
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
[TBL] [Abstract][Full Text] [Related]
13. The impact of variable relative biological effectiveness in proton therapy for left-sided breast cancer when estimating normal tissue complications in the heart and lung.
Marteinsdottir M; Wang CC; McNamara A; Depauw N; Shin J; Paganetti H
Phys Med Biol; 2021 Jan; 66(3):035023. PubMed ID: 33522498
[TBL] [Abstract][Full Text] [Related]
14. Impact of respiratory motion on variable relative biological effectiveness in 4D-dose distributions of proton therapy.
Ulrich S; Wieser HP; Cao W; Mohan R; Bangert M
Acta Oncol; 2017 Nov; 56(11):1420-1427. PubMed ID: 28828913
[TBL] [Abstract][Full Text] [Related]
15. Difference in LET-based biological doses between IMPT optimization techniques: Robust and PTV-based optimizations.
Hirayama S; Matsuura T; Yasuda K; Takao S; Fujii T; Miyamoto N; Umegaki K; Shimizu S
J Appl Clin Med Phys; 2020 Apr; 21(4):42-50. PubMed ID: 32150329
[TBL] [Abstract][Full Text] [Related]
16. Comparative photon and proton dosimetry for patients with mediastinal lymphoma in the era of Monte Carlo treatment planning and variable relative biological effectiveness.
Tseng YD; Maes SM; Kicska G; Sponsellor P; Traneus E; Wong T; Stewart RD; Saini J
Radiat Oncol; 2019 Dec; 14(1):243. PubMed ID: 31888769
[TBL] [Abstract][Full Text] [Related]
17. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
[TBL] [Abstract][Full Text] [Related]
18. Exploration and application of phenomenological RBE models for proton therapy.
Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
[TBL] [Abstract][Full Text] [Related]
19. Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.
Pedersen J; Petersen JBB; Stokkevåg CH; Ytre-Hauge KS; Flampouri S; Li Z; Mendenhall N; Muren LP
Acta Oncol; 2017 Nov; 56(11):1413-1419. PubMed ID: 29037095
[TBL] [Abstract][Full Text] [Related]
20. Impact of physiological breathing motion for breast cancer radiotherapy with proton beam scanning - An in silico study.
Flejmer AM; Chehrazi B; Josefsson D; Toma-Dasu I; Dasu A
Phys Med; 2017 Jul; 39():88-94. PubMed ID: 28606833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]